The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law
The FDA approval is based on the OASIS 4 Phase 3 clinical trial a 64-week study of 307 adults with obesity or overweight and at least one weight-related health condition (such as high blood pressure, high cholesterol, or prediabetes), but without type 2 diabetes
For everyone else, including uninsured individuals who dont meet income requirements, people with Medicare or Medicaid, and those whose insurance explicitly excludes weight loss medications, compounded semaglutide at $199 monthly is by far the most affordable option
Highland prescribes compounded tirzepatide only
In any case, theres a lack of large-scale, long-term research in humans to back up Aspreys more grandiose claims about his diet
Pathogenesis underlying neurological manifestations of long COVID syndrome and potential therapeutics